-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Integrating Germline Investigation for Hematologic Malignancies in the Clinical Setting: The Swedish Experience

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: How Scientific Advances Impact Clinical Predictive Models and Recommendations
Friday, December 8, 2023, 4:18 PM-4:59 PM

Panagiotis Baliakas, MD

Immunology, genetics and pathology, Uppsala University, Uppsala, Sweden

Disclosures: No relevant conflicts of interest to declare.